LOTUSEYE Share Price Target 2050

CAGR-based price projection for Lotus Eye Hospital and Institute Limited (LOTUSEYE) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (3.1% CAGR)
Rs 238
2050 Target
Base Case (7.6% CAGR)
Rs 675
2050 Target
Bull Case (20.6% CAGR)
Rs 10,351
2050 Target

Current Market Snapshot

CMP: Rs 115.68
52W High: Rs 139.98
52W Low: Rs 104.74
1Y CAGR: 15.8%
3Y CAGR: 7.6%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 119 Rs 125 Rs 140
2028 Rs 123 Rs 134 Rs 168
2029 Rs 127 Rs 144 Rs 203
2030 Rs 130 Rs 155 Rs 245
2031 Rs 134 Rs 167 Rs 295
2032 Rs 139 Rs 180 Rs 356
2033 Rs 143 Rs 194 Rs 429
2034 Rs 147 Rs 208 Rs 517
2035 Rs 152 Rs 224 Rs 624
2036 Rs 156 Rs 241 Rs 752
2037 Rs 161 Rs 260 Rs 907
2038 Rs 166 Rs 280 Rs 1,094
2039 Rs 171 Rs 301 Rs 1,320
2040 Rs 176 Rs 324 Rs 1,591
2041 Rs 182 Rs 349 Rs 1,919
2042 Rs 187 Rs 375 Rs 2,314
2043 Rs 193 Rs 404 Rs 2,791
2044 Rs 199 Rs 435 Rs 3,366
2045 Rs 205 Rs 468 Rs 4,059
2046 Rs 211 Rs 503 Rs 4,894
2047 Rs 217 Rs 542 Rs 5,902
2048 Rs 224 Rs 583 Rs 7,118
2049 Rs 231 Rs 628 Rs 8,583
2050 Rs 238 Rs 675 Rs 10,351

Other LOTUSEYE Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the LOTUSEYE share price target for 2050?

Based on historical growth analysis, the LOTUSEYE share price target for 2050 ranges from Rs 238 (conservative) to Rs 675 (base case) to Rs 10,351 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of LOTUSEYE?

The current market price of LOTUSEYE (Lotus Eye Hospital and Institute Limited) is Rs 115.68. The 52-week high is Rs 139.98 and 52-week low is Rs 104.74.

Is LOTUSEYE a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for LOTUSEYE price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 3.1% CAGR), Base (7.6% CAGR), and Bull (optimistic at 20.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.